IP Café – From Idea to IP: Turning science into strategic assets for biotech innovators

We are pleased to invite you to our next IP Café, organised by De Clercq & Partners: to share insights and practical experience to transform scientific ideas into valuable strategic IP assets, combining short presentations with interactive interview-style discussions.
 
Successfully protecting and leveraging biotech innovation often requires navigating the interface between fundamental research, applied development, regulatory considerations and commercial strategy. This creates both opportunities and challenges for biotech innovators, research institutes and industry partners alike.

Join us as we explore this topic through expert insights from our biotech patent attorneys Delphine Debruyne, Annelies De Clercq, and Lieve Coenegrachts, and Aphea.Bio’s head of IP: Wim Grunewald.